In the Opportunity Zone
The opportunity zone program aims to stoke investment in underserved areas, but until investors receive clarifications, the program's impact remains unclear.
Baby Steps
By providing OB-GYN departments with physicians around the clock, Ob Hospitalist Group is changing the way women's health is delivered.
Middle-Market Public Policy Roundup
The IRS released the long-awaited guidance on opportunity zones and ACG attended a White House conference where officials, including President Donald Trump, voiced support of the program.
Former LVMH Exec Pauline Brown on Building Better Brands
Pauline Brown, the former chairman of North America for LVMH, offers insight from her career as an operator and investor in the luxury goods industry.
It’s the Small Things: Trends in Human Capital
Six trends in human capital and talent management.
Middle-Market Public Policy Roundup
ACG announces Middle Market Fly-In, regulators examine opportunity zones and the Trump Administration accelerates the review process for "major" regulations.
Comprehensive Pharmacy Services Announces Sale to Frazier Healthcare Partners
Frazier Healthcare Partners provides private equity capital to health care companies.
A Qualified Opinion: Jason W. Downing
The Deloitte vice chairman discusses how new technology is affecting hiring at middle market companies.
After Years-Long Decline in Interest, Business Schools Are Writing a New Lesson Plan
As unemployment falls and tuition rises, business schools are being forced to innovate MBA programs in order to bring students into the classroom.
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Paragon was acquired by Calent from a group of private equity investors.
